English
We provide comperhensivesourcing, supply, and compliance solutions for Active Pharmaceutical Ingredients （APIs), linking trusted manufacturers with global pharmaceutical companiesto ensure a reliable supply chainand regulatory compliance. Specialties: Small Molecule APIs|Peptides|Oligonucleotides
We provide global procurement and supply services covering small molecule active pharmaceutical ingredients, peptides, and oligonucleotides: in terms of process, from demand matching and compliance supplier screening to sample testing, batch production follow-up, and cold chain logistics distribution, the entire chain is controllable; At the standard level, we strictly follow international standards such as ICH Q7 and GMP, with raw material purity ≥ 99%. Oligonucleotide synthesis adopts automated processes, and COA testing reports are attached to each batch to ensure quality traceability. We also provide customized purification and cold chain solutions to meet research and development and production needs.
Business scope: medical device sales, medical consumable delivery, laboratory equipment consumables, SPD fine management
Antibody production can be divided into three major stages: upstream (cell culture to harvest), downstream (purification to filling), and formulation. According to the process, a complete upstream and downstream process system can be provided for the preparation of denosumab, tocilizumab, rituximab, trastuzumab, etc.
GENO Pharmaceutical Technology Co., Ltd. is committed to becoming a global supplier of comprehensive solutions for the clean industry. We are not only builders of clean engineering, but also full partners for global owners from 0 to 1.
